HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.

Abstract
Tumor suppressor gene BRCA1 is frequently mutated in familial breast and ovarian cancer. BRCA1 plays pivotal roles in maintaining genomic stability by interacting with numerous proteins in cell cycle control and DNA repair. Irofulven (6-hydroxymethylacylfulvene, HMAF, MGI 114, NSC 683863) is one of a new class of anticancer agents that are analogs of mushroom-derived illudin toxins. Preclinical studies and clinical trials have demonstrated that irofulven is effective against several tumor cell types. The exact nature of irofulven-induced DNA damage is not completely understood. We demonstrated previously that irofulven activates ATM and its targets, NBS1, SMC1, CHK2, and p53. In this study, we hypothesize that irofulven induces DNA double-strand breaks and that BRCA1 may affect chemosensitivity by controlling cell cycle checkpoints, DNA repair, and genomic stability in response to irofulven treatment. We observed that irofulven induces the formation of chromosome breaks and radials and the activation and foci formation of gamma-H2AX, BRCA1, and RAD51. We also provided evidence that irofulven induces the generation of DNA double-strand breaks. By using BRCA1-deficient or -proficient cells, we demonstrated that in response to irofulven, BRCA1 contributes to the control of S and G(2)/M cell cycle arrest and is critical for repairing DNA double-strand breaks and for RAD51-dependent homologous recombination. Furthermore, we found that BRCA1 deficiency results in increased chromosome damage and chemosensitivity after irofulven treatment.
AuthorsTimothy Wiltshire, Jamie Senft, Yutian Wang, Gregory W Konat, Sharon L Wenger, Eddie Reed, Weixin Wang
JournalMolecular pharmacology (Mol Pharmacol) Vol. 71 Issue 4 Pg. 1051-60 (Apr 2007) ISSN: 0026-895X [Print] United States
PMID17229870 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • BRCA1 Protein
  • Cell Cycle Proteins
  • Sesquiterpenes
  • irofulven
  • Rad51 Recombinase
Topics
  • Antineoplastic Agents (pharmacology)
  • BRCA1 Protein (drug effects, physiology)
  • Cell Cycle (drug effects)
  • Cell Cycle Proteins (drug effects)
  • Cell Line, Tumor
  • Chromosome Breakage
  • DNA Damage (drug effects)
  • DNA Repair
  • Drug Resistance (drug effects)
  • Genomic Instability
  • Humans
  • Rad51 Recombinase (drug effects)
  • Sesquiterpenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: